Intrepid Family Office’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-65,000
Closed -$1.65M 41
2025
Q1
$1.65M Hold
65,000
2.32% 14
2024
Q4
$1.72M Buy
+65,000
New +$1.76M 1.8% 15
2023
Q3
$1.09M Buy
33,000
+5,500
+20% +$194K 1.75% 20
2023
Q2
$1.01M Buy
27,500
+17,500
+175% +$681K 1.92% 16
2023
Q1
$408K Buy
+10,000
New +$432K 0.89% 20
2022
Q1
Sell
-50,000
Closed -$2.95M 35
2021
Q4
$2.95M Buy
+50,000
New +$2.48M 3.36% 14

Other funds holding PFE

Intrepid Family Office's PFE Position: Q2 2025 in Review

Intrepid Family Office sold out of Pfizer (PFE) in Q2 2025, closing a stake of 65,000 shares — an estimated $1.65M sold.

Intrepid Family Office first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $2.95M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Intrepid Family Office reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Intrepid Family Office sold 65,000 Pfizer shares in Q2 2025, an estimated $1.65M.
  • Intrepid Family Office first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
  • Intrepid Family Office's Pfizer position peaked at $2.95M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Intrepid Family Office's 13F filing for Q2 2025, filed 14 Aug 2025.